Table 2.
Indication for hemithyroidectomy and postoperative pathology results.
| Characteristics | Values |
|---|---|
| Total, n | 143 |
| Incidental focal lesion, n (%) | 46 (32) |
| PET-CT, n | 33 |
| Neck-CT, n | 7 |
| Neck-MRI, n | 4 |
| Neck-US, n | 2 |
| Goiter or nodule, n (%) | 97 (68) |
| Compressive, n | 33 |
| Cosmetic, n | 8 |
| PTC, n (%) | 137 (96) |
| Incidental, n (% of PTC)* | 60 (44) |
| Tumor size, mm | 3 (2.0–4.5) |
| Suspected malign nodule, n (% of PTC) | 83 (66%) |
| Tumor size, mm | 12 (9–17) |
| Multifocal disease, n (% of PTC) | 6 (5) |
| FTC, n (%) | 6 (4) |
| Concomitant benign nodular goiter, n (%) | 85 (59) |
| Concomitant lymphocytic thyroiditis, n (%) | 11 (8) |
| Tumor size, mm | 8 (3–13) |
Incidental findings during routine pathologic examination after HT for goiter.
PET-CT, positron emission tomography–computed tomography; MRI, magnetic resonance imaging; US, ultrasound scan; DTC, differentiated thyroid cancer; PTC, papillary thyroid cancer; FTC, follicular thyroid cancer.
This work is licensed under a